Comination of a hypnotic agent and R(+)-alpha-(2,3-dimethoxy-phenyl)-1-(2 - (4-fluorophenl)ethyl)-4-piperidinemetha nol and therapeutic application thereof

Details for Australian Patent Application No. 2006283702 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors Emmons, Gary T.; Kongsamut, Sathapana; Karson, Craig N.; Legoff, Corinne M.

Agent Watermark

Pub. Number AU-A-2006283702

PCT Pub. Number WO2007/024599

Priority 60/709,510 19.08.05 US

Filing date 16 August 2006

Wipo publication date 1 March 2007

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/437 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/024599 Priority application(s): WO2007/024599

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283703-Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof

2006283693-Controlled release of additive gel(s) for functional fluids